TUESDAY, Jan. 30 (HealthDay News) — Dutch researchers may have a new method of predicting whether patients with arthritic symptoms will progress to the autoimmune form of the disease, rheumatoid arthritis.
Read full story
Juvenile idiopathic arthritis (JIA) is the most common rheumatic disease in childhood, yet unlike adult arthritis, little is known about its economic impact.
Read full story
January 29, 2007
Roche’s rheumatoid arthritis trial result positive (PharmaBiz)
Roche has announced that ‘Option’1, the first multinational phase III study of Actemra (tocilizumab) outside of Japan, successfully met its primary endpoint in the group of patients with moderate to severe rheumatoid arthritis (RA) who had an inadequate response to methotrexate.
Read full story
January 27, 2007
Arthritis sufferers in RP to exceed 2.6M (INQ7.net)
THE DEBILITATING, agonizing pain of arthritis and rheumatism is such that sufferers sometimes prefer death over a lifetime of torment.
Read full story
